Mining the dark matter of the cancer proteome for novel biomarkers

Current Cancer Therapy Reviews

Volumn 9, Issue 4, 2013, Pages 265-277

  Delgado, Ana Paula ^a   Brandao, Pamela ^a   Hamid, Sheilin ^a   Narayanan, Ramaswamy ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

C1ORF87; CREF gene; Druggable genes; Post genome; Uncharacterized genes

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CARCINOMA RELATED EF HAND PROTEIN; INTERLEUKIN 7; K RAS PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN P53; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG;

BIOINFORMATICS; BREAST CARCINOMA; CANCER CELL LINE; CANCER TISSUE; DATA BASE; DATA MINING; DOWN REGULATION; DRUG TARGETING; EXPERIMENTAL DESIGN; GENETIC ASSOCIATION; HUMAN; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; NEOPLASM; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR GENE;

EID: 84900798283     PISSN: 15733947     EISSN: 18756301     Source Type: Journal    
DOI: 10.2174/1573394710666140313003905     Document Type: Review

References (112)

1. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409(6822): 860-921.
2. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291(5507): 1304-51.
3. Wheeler DA, Wang L. From human genome to cancer genome: the first decade. Genome research 2013; 23(7): 1054-62.
4. Alfoldi J, Lindblad-Toh K. Comparative genomics as a tool to understand evolution and disease. Genome research 2013; 23(7): 1063-8.
5. Brunschweiger A, Hall J. A decade of the human genome se-quence--how does the medicinal chemist benefit? Chem Med Chem 2012; 7(2): 194-203.
6. Pertea M, Salzberg SL. Between a chicken and a grape: estimating the number of human genes. Genome biology 2010; 11(5): 206.
7. Strausberg RL. The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer. The Journal of pathology 2001; 195(1): 31-40.
8. Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R. Cancer gene discovery using digital differential display. Cancer research 2000; 60(15): 4037-43.
9. De Young MP, Damania H, Scheurle D, Zylberberg C, Narayanan R. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer. In vivo 2002; 16(4): 239-48.
10. Narayanan R. Bioinformatics approaches to cancer gene discovery. Methods Mol Biol 2007; 360: 13-31.
11. Schmitt AO. Mining expressed sequence tag (EST) libraries for cancer-associated genes. Methods Mol Biol 2010; 576: 89-98.
12. Lauriola M, Ugolini G, Rosati G, et al. Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood.Int J Oncol2010; 37(2): 519-25.
13. Boon K, Osorio EC, Greenhut SF, et al. An anatomy of normal and malignant gene expression. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(17): 11287-92.
14. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome research 2002; 12(6): 996-1006.
15. Parkinson H, Sarkans U, Shojatalab M, et al. ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2005; 33(Database issue): D553-5.
16. Kuntzer J, Maisel D, Lenhof HP, Klostermann S, Burtscher H. The Roche Cancer Genome Database 2.0. BMC medical genomics. 2011; 4: 43.
17. Halling-Brown MD, Bulusu KC, Patel M, Tym JE, Al-Lazikani B. canSAR: an integrated cancer public translational research and drug discovery resource. Nucleic Acids Res 2012; 40(Database issue): D947-56.
18. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39(Database issue): D945-50.
19. Monga M, Sausville EA. Developmental therapeutics program at the NCI: molecular target and drug discovery process. Leukemia 2002; 16(4): 520-6.
20. Liu F, White JA, Antonescu C, Gusenleitner D, Quackenbush J. GCOD - GeneChip Oncology Database. BMC bioinformatics 2011; 12: 46.
21. Hopkins AL, Groom CR. The druggable genome. Nature reviews Drug discovery 2002; 1(9): 727-30.
22. Hauptman N, Glavac D. MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer. Radiol Oncol 2013; 47(4): 311-8.
23. Costa PM, Pedroso de Lima MC. MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression. Pharmaceuticals 2013; 6(10): 1195-220.
24. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. Mi-croRNA targets in Drosophila. Genome biology 2003; 5(1): R1.
25. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA binding sites by walking the genes of three genomes. J Biomed Inform 2011; 44(5): 839-47.
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115(7): 787-98.
27. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 2009; 37(Database issue): D105-10.
28. Jiang Q, Wang Y, Hao Y, et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009; 37(Database issue): D98-104.
29. Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bio-informatics 2013; 29(5): 638-44.
30. Martin L, Chang HY. Uncovering the role of genomic dark matter in human disease. The J Clin Invest 2012; 122(5): 1589-95.
31. Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell. 2011; 145(2): 178-81.
32. Mak L, Liggi S, Tan L, Kusonmano K, et al. Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism. Curr Pharm Des 2013; 19(4): 532-77.
33. Natrajan R, Wilkerson P. From integrative genomics to therapeutic targets. Cancer research 2013; 73(12): 3483-8.
34. Nevins JR, Potti A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat Rev Genet 2007; 8(8): 601-9.
35. Chung CW. Small molecule bromodomain inhibitors: extending the druggable genome. Prog Med Chem 2012; 51: 1-55.
36. Griffith M, Griffith OL, Coffman AC, et al. DGIdb: mining the druggable genome. Nature methods 2013; 10(12): 1209-10.
37. Rask-Andersen M, Almen MS, Schioth HB. Trends in the exploitation of novel drug targets. Nature reviews Drug discovery 2011; 10(8): 579-90.
38. Russ AP, Lampel S. The druggable genome: an update. Drug discovery today 2005; 10(23-24): 1607-10.
39. Zhu F, Han B, Kumar P, et al. Update of TTD: Therapeutic Target Database. Nucleic Acids Res 2010; 38(Database issue): D787-91.
40. Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006; 34(Database issue): D668-72.
41. Knox C, Law V, Jewison T, et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011; 39(Database issue): D1035-41.
42. Li J, Duncan DT, Zhang B. CanProVar: a human cancer proteome variation database. Human mutation 2010; 31(3): 219-28.
43. Nadzirin N, Firdaus-Raih M. Proteins of Unknown Function in the Protein Data Bank (PDB): An Inventory of True Uncharacterized Proteins and Computational Tools for Their Analysis. Int J Mol Sci 2012; 13(10): 12761-72.
44. Babcock JJ, Li M. Deorphanizing the human transmembrane genome: A landscape of uncharacterized membrane proteins. Acta Pharmacol Sin 2014; 35(1): 11-23. doi: 10.1038/aps.2013.142. Epub 2013 Nov 18.
45. UniProt C. Update on activities at the Universal Protein Resource (UniProt) in 2013. Nucleic Acids Res 2013; 41(Database issue): D43-7.
46. Safran M, Dalah I, Alexander J, et al. GeneCards Version 3: the human gene integrator. Database: the journal of biological databases and curation 2010; 2010: baq020.
47. Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 2012; 40(Web Server issue): W597-603.
48. Rost B, Yachdav G, Liu J. The PredictProtein server. Nucleic Acids Res 2004; 32(Web Server issue): W321-6.
49. Cong Q, Grishin NV. MESSA: MEta-Server for protein Sequence Analysis. BMC biology 2012; 10: 82.
50. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007; 9(2): 166-80.
51. Kupershmidt I, Su QJ, Grewal A, et al. Ontology-based meta-analysis of global collections of high-throughput public data. PloS one 2010; 5(9).
52. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. The Akt/PKB pathway: molecular target for cancer drug discovery. On-cogene 2005; 24(50): 7482-92.
53. Chelala C, Lemoine NR, Hahn SA, Crnogorac-Jurcevic T. A web-based platform for mining pancreatic expression datasets. Pancrea-tology: official journal of the International Association of Pancrea-tology 2009; 9(4): 340-3.
54. Mohandass J, Ravichandran S, Srilakshmi K, Rajadurai CP, San-mugasamy S, Kumar GR. BCDB - A database for breast cancer research and information. Bioinformation 2010; 5(1): 1-3.
55. Kao S, Shiau CK, Gu DL, et al. IGDB.NSCLC: integrated genomic database of non-small cell lung cancer. Nucleic Acids Res 2012; 40(Database issue): D972-7.
56. Dayem Ullah AZ, Cutts RJ, Ghetia M, et al. The pancreatic expression database: recent extensions and updates. Nucleic Acids Res 2013.
57. Maqungo M, Kaur M, Kwofie SK, et al. DDPC: Dragon Database of Genes associated with Prostate Cancer. Nucleic Acids Res 2011; 39(Database issue): D980-5.
58. Kaur M, Radovanovic A, Essack M, et al. Database for exploration of functional context of genes implicated in ovarian cancer. Nucleic Acids Res 2009; 37(Database issue): D820-3.
59. Essack M, Radovanovic A, Schaefer U, et al. DDEC: Dragon database of genes implicated in esophageal cancer. BMC cancer 2009; 9: 219.
60. Brylinski M. Exploring the dark matter of a mammalian pro-teome by protein structure and function modeling. Proteome science 2013; 11(1): 47.
61. Blaxter M. Genetics. Revealing the dark matter of the genome. Science 2010; 330(6012): 1758-9.
62. Korhonen A, Seaghdha DO, Silins I, Sun L, Hogberg J, Stenius U. Text mining for literature review and knowledge discovery in cancer risk assessment and research. PloS one 2012; 7(4): e33427.
63. Aguiar-Pulido V, Seoane JA, Gestal M, Dorado J. Exploring patterns of epigenetic information with data mining techniques. Curr Pharm Des 2013; 19(4): 779-89.
64. Zhu F, Patumcharoenpol P, Zhang C, et al. Biomedical text mining and its applications in cancer research. J Biomed Inform 2013; 46(2): 200-11.
65. Rivenbark AG, Coleman WB. Dissecting the molecular mechanisms of cancer through bioinformatics-based experimental approaches. J Cell Biochem 2007; 101(5): 1074-86.
66. Alibes A, Yankilevich P, Canada A, Diaz-Uriarte R. IDconverter and IDClight: conversion and annotation of gene and protein IDs. BMC bioinformatics 2007; 8: 9.
67. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature genetics 2001; 29(4): 365-71.
68. Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010; 28(12): 1248-50.
69. Kolker E, Higdon R, Haynes W, et al. MOPED: Model Organism Protein Expression Database. Nucleic Acids Res 2012; 40(Database issue): D1093-9.
70. Mathivanan S, Ahmed M, Ahn NG, et al. Human Proteinpedia enables sharing of human protein data. Nature biotechnology 2008; 26(2): 164-7.
71. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human Protein Reference Database--2009 update. Nucleic Acids Res 2009; 37(Database issue): D767-72.
72. Shen EH, Overly CC, Jones AR. The Allen Human Brain Atlas: comprehensive gene expression mapping of the human brain. Trends Neurosci 2012; 35(12): 711-4.
73. Marchler-Bauer A, Zheng C, Chitsaz F, et al. CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Res 2013; 41(Database issue): D348-52.
74. Finn RD, Bateman A, Clements J, et al. Pfam: the protein families database. Nucleic Acids Res 2013.
75. Hunter S, Jones P, Mitchell A, et al. InterPro in 2011: new developments in the family and domain prediction database. Nucleic Acids Res 2012; 40(Database issue): D306-12.
76. Servant F, Bru C, Carrere S, et al. ProDom: automated clustering of homologous domains. Brief Bioinform 2002; 3(3): 246-51.
77. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18(15): 2714-23.
78. Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer ge-nomics data. Cancer discovery 2012; 2(5): 401-4.
79. Sur I, Tuupanen S, Whitington T, Aaltonen LA, Taipale J. Lessons from functional analysis of genome-wide association studies. Cancer research 2013; 73(14): 4180-4.
80. Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41(Database issue): D808-15.
81. Rual JF, Venkatesan K, Hao T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005; 437(7062): 1173-8.
82. Cowley MJ, Pinese M, Kassahn KS, et al. PINA v2.0: mining interactome modules. Nucleic Acids Res 2012; 40(Database issue): D862-5.
83. Licata L, Briganti L, Peluso D, et al. MINT, the molecular interaction database: 2012 update Nucleic Acids Res 2012; 40(Database issue): D857-61.
84. Orchard S, Ammari M, Aranda B, et al. The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res 2013.
85. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006; 34(Database issue): D535-9.
86. Finn RD, Clements J, Eddy SR. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 2011; 39(Web Server issue): W29-37.
87. Katt WP, Cerione RA. Glutaminase regulation in cancer cells: a druggable chain of events. Drug Discov Today 2013.
88. Sioud M, Leirdal M. Druggable signaling proteins. Methods Mol Biol 2007; 361: 1-24.
89. Stegh AH. Targeting the p53 signaling pathway in cancer therapy -the promises, challenges and perils. Expert Opin Ther Targets 2012; 16(1): 67-83.
90. Chizhikov V, Zborovskaya I, Laktionov K, et al. Two consistently deleted regions within chromosome 1p32-pter in human non-small cell lung cancer. Molecular carcinogenesis 2001; 30(3): 151-8.
91. Gasparian AV, Laktionov KK, Belialova MS, Pirogova NA, Tato-syan AG, Zborovskaya IB. Allelic imbalance and instability of mi-crosatellite loci on chromosome 1p in human non-small-cell lung cancer. Br J Cancer 1998; 77(10): 1604-11.
92. Smyth I, Narang MA, Evans T, et al. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. Human molecular genetics 1999; 8(2): 291-7.
93. Opocher G, Schiavi F, Vettori A, et al. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma. Clinical endocrinology 2003; 59(6): 707-15.
94. Huret JL, Ahmad M, Arsaban M, et al. Atlas of genetics and cyto-genetics in oncology and haematology in 2013. Nucleic Acids Res 2013; 41(Database issue): D920-4.
95. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314(5797): 268-74.
96. Ofran Y, Rost B. ISIS: interaction sites identified from sequence. Bioinformatics 2007; 23(2): e13-6.
97. Amanchy R, Periaswamy B, Mathivanan S, Reddy R, Tattikota SG, Pandey A. A curated compendium of phosphorylation motifs. Nature biotechnology 2007; 25(3): 285-6.
98. Hansen JE, Lund O, Tolstrup N, Gooley AA, Williams KL, Brunak S. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility. Glycoconjugate journal 1998; 15(2): 115-30.
99. Ma X, Wang YW, Zhang MQ, Gazdar AF. DNA methylation data analysis and its application to cancer research. Epigenomics 2013; 5(3): 301-16.
100. Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer research 2013; 33(8): 2989-96.
101. Takagi K, Ito S, Miyazaki T, et al. Amyloid precursor protein in human breast cancer: An androgen-induced gene associated with cell proliferation. Cancer science 2013.
102. Ikura M, Osawa M, Ames JB. The role of calcium-binding proteins in the control of transcription: structure to function. BioEssays: news and reviews in molecular, cellular and developmental biology. 2002; 24(7): 625-36.
103. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2008; 34(4): 357-64.
104. Heizmann CW, Ackermann GE, Galichet A. Pathologies involving the S100 proteins and RAGE. Sub-cellular biochemistry 2007; 45: 93-138.
105. Gibadulinova A, Tothova V, Pastorek J, Pastorekova S. Transcriptional regulation and functional implication of S100P in cancer. Amino acids 2011; 41(4): 885-92.
106. 2+ signaling by neuronal Ca2+-sensor proteins: from Alzheimer's disease to cancer. Trends in Pharmacological Sciences 2005; 26(7): 345-51.
107. Wolf S, Haase-Kohn C, Pietzsch J. S100A2 in cancerogenesis: a friend or a foe? Amino acids 2011; 41(4): 849-61.
108. Yanez M, Gil-Longo J, Campos-Toimil M. Calcium binding proteins. Advances in experimental medicine and biology 2012; 740: 461-82.
109. Subramanian L, Polans AS. Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins. Biochem Biophys Res Commun 2004; 322(4): 1153-65.
110. Leclerc E, Heizmann CW. The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine. Front Biosci 2011; 3: 1232-62.
111. Hwang SK, Piao L, Lim HT, et al. Suppression of lung tumori-genesis by leucine zipper/EF hand-containing transmembrane-1. PloS one 2010; 5(9).
112. Tsai WC, Lin YC, Tsai ST, et al. Lack of modulatory function of coding nucleotide polymorphism S100A2_185G>A in oral squamous cell carcinoma. Oral Diseases 2011; 17(3): 283-90.